Daejeon, South Korea

Kim Chi Hyun


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kim Chi Hyun: Innovator in Anti-Inflammatory Research

Introduction

Kim Chi Hyun is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory compounds. His innovative work has led to the creation of a novel compound that holds promise for treating various inflammatory diseases.

Latest Patents

Kim Chi Hyun holds a patent for a compound titled "6-Alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor." This invention relates to a unique 6-alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative. The compound demonstrates a high inhibitory effect on 5-lipoxygenase (5-LO) activity, which is crucial for preventing and treating diseases related to leukotriene activation, such as rheumatoid arthritis, colitis, asthma, and psoriasis.

Career Highlights

Kim Chi Hyun is affiliated with the Korea Research Institute of Chemical Technology, where he conducts his research. His work is characterized by a focus on high-efficiency synthesis methods, particularly through combinatorial chemical synthetic techniques. His dedication to advancing medicinal chemistry has positioned him as a key figure in his field.

Collaborations

Kim has collaborated with notable colleagues, including Young-Dae Gong and Hyae-Gyeong Cheon. These partnerships have enhanced the scope and impact of his research, contributing to the development of innovative solutions in the realm of anti-inflammatory treatments.

Conclusion

Kim Chi Hyun's contributions to the field of medicinal chemistry, particularly through his patented anti-inflammatory compound, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…